Highlights Integrum AB

Equities

INTEG B

SE0009807266

Delayed Nasdaq Stockholm Other stock markets 05:51:40 2024-06-03 am EDT			5-day change	1st Jan Change
51.2 ^SEK	+0.79%		-6.57%	+12.16%

May. 29	Integrum Receives Market Approval for Opra®? Implant System in Israel	CI
May. 15	Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Integrum Receives Market Approval for Opra®? Implant System in Israel	May. 29	CI
Integrum Announces It Has Been Granted A Registered Trademark for OPRA® Implant System in the Eu	May. 15	CI
Integrum Expands Its Product Offering to the United Kingdom Market	May. 02	CI
Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel	Mar. 26	CI
Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Feb. 28	CI
Integrum Sells and Delivers Opratm Implant Systems to A Value of SEK 3.5 Million to Center of Excellence in Ukraine	Jan. 31	CI
Integrum AB Establishes Center of Excellence in Ukraine	Dec. 20	CI
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 03	CI
Integrum AB Plans to Submit a PMA Application to the FDA for the Use of OPRA in Transhumeral Implantations Based on Existing Clinical Data	Nov. 13	CI
Integrum AB Provides Earnings Guidance for the Second Quarter of 2023	Nov. 10	CI
Integrum Announces US Department of Defense Decided to Fully Fund a Clinical Study of OPRA(TM) Implant System on Up to 30 Patients with Transtibial (Below-Knee) Amputations	Nov. 10	CI
Integrum's Opra?? Implant System Gets Fda Approval for Clinical Study on Below-Knee Amutationations	23-10-30	CI
Integrum Enters into the Turkey Market	23-10-27	CI
Integrum Announces Long-Term Follow-Up Patient Who Received A Human-Machine Bionic Hand Prosthesis, Utilizing	23-10-12	CI
Integrum Announces Long-Term Integrated Bionic Hand Enriched with Motor and Sensory AI	23-10-12	CI
Integrum Receives Unitary Patent for Neuromotus in the EU	23-10-10	CI
Integrum Initiates A Strategic Review Process to Accelerate Growth	23-09-14	CI
Integrum AB Receives Reimbursement Code for Axor II	23-09-08	CI
Integrum AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-08-30	CI
Analysis-Small firms offer private equity job market bright spot	23-07-26	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Integrum AB

Equities

INTEG B

SE0009807266

Highlights

Filters